Clinical Experience with Use of Remdesivir in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: a Case Series.

Choongman Lee Mi Young Ahn Kyeongmin Byeon Jae Phil Choi Chorom Hahm Hyeonmok Kim Suhyun Kim Tae Ho Kim JungKyun Oh Dong Hyun Oh

Published in: Infection & chemotherapy (2020)

Our experience indicates that RDV could be a therapeutic option for COVID-19. A well-designed randomized controlled clinical trial is now needed to confirm the efficacy of RDV in patients with COVID-19.

Keyphrases

respiratory syndrome coronavirus
sars cov
coronavirus disease
combination therapy
replacement therapy